TELA Bio (TELA) Revenue Growth (1y) (2019 - 2026)
TELA Bio (TELA) Revenue Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 13.02% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 9.42% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 7.53% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 13.63% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 13.08% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 5.75% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 95.64% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 7.30% |
| 10 | TELA Bio | 36.34 Mn | 5.92 Mn | 13.94 Mn | -4.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.49% |
| Mar 31, 2026 | 2.91% |
| Dec 31, 2025 | 18.24% |
| Sep 30, 2025 | 9.14% |
| Jun 30, 2025 | 25.52% |
| Mar 31, 2025 | 11.55% |
| Dec 31, 2024 | 3.83% |
| Sep 30, 2024 | 25.94% |
| Jun 30, 2024 | 11.02% |
| Mar 31, 2024 | 39.42% |
| Dec 31, 2023 | 46.26% |
| Sep 30, 2023 | 34.89% |
| Jun 30, 2023 | 39.29% |
| Mar 31, 2023 | 44.68% |
| Dec 31, 2022 | 38.79% |
| Sep 30, 2022 | 45.79% |
| Jun 30, 2022 | 37.68% |
| Mar 31, 2022 | 40.05% |
| Dec 31, 2021 | 47.77% |
| Sep 30, 2021 | 44.06% |